Stay updated on Long-term Safety of BI 655130 in Atopic Eczema: Clinical Trial
Sign up to get notified when there's something new on the Long-term Safety of BI 655130 in Atopic Eczema: Clinical Trial page.

Latest updates to the Long-term Safety of BI 655130 in Atopic Eczema: Clinical Trial page
- Check3 days agoChange DetectedThe site revision displayed in the footer changed from v3.7.2 to v3.8.0, while the study page remains inaccessible.SummaryDifference0.3%

- Check10 days agoChange DetectedA site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check17 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check24 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 error.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now displays a 403 Forbidden error, showing an access-denied message with the site header and footer, instead of the expected study content.SummaryDifference17%

- Check67 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous v3.6.5. This reflects a newer page revision, with no change to the study details.SummaryDifference0.1%

Stay in the know with updates to Long-term Safety of BI 655130 in Atopic Eczema: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Safety of BI 655130 in Atopic Eczema: Clinical Trial page.